Merger of two major Huntington’s Disease observational trials creates ENROLL-HD
Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex
DOMINO clinical trial result: minocycline doesn’t slow down HD and shouldn’t be studied in larger trials.
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers